Citadel Advisors’s PolyPid PYPD Stock Holding History

Citadel Advisors’s Portfolio PYPD Stock Details PYPD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$215K	Sell	42,282 -15,487	-27%	-$71.4K	﹤0.01%	11906
2026 Q1	$253K	Buy	57,769 +47,046	+439%	+$208K	﹤0.01%	10881
2025 Q4	$46.5K	Buy	+10,723	New	+$39.8K	﹤0.01%	12066
2025 Q3	–	Sell	-13,151	Closed	-$46.4K	–	13833
2025 Q2	$46.4K	Buy	13,151 +2,593	+25%	+$7.59K	﹤0.01%	11807
2025 Q1	$28.6K	Buy	+10,558	New	+$31.5K	﹤0.01%	12865
2023 Q1	–	Sell	-18	Closed	-$384	–	15344
2022 Q4	$384	Sell	18 -388	-96%	-$10K	﹤0.01%	14679
2022 Q3	$14K	Sell	406 -470	-54%	-$58.1K	﹤0.01%	12179
2022 Q2	$122K	Sell	876 -267	-23%	-$40K	﹤0.01%	11193
2022 Q1	$187K	Buy	1,143 +736	+181%	+$111K	﹤0.01%	11619
2021 Q4	$70K	Buy	+407	New	+$85.9K	﹤0.01%	13030
2021 Q1	–	Sell	-629	Closed	-$188K	–	13614
2020 Q4	$188K	Buy	+629	New	+$200K	﹤0.01%	9786
2020 Q3	–	Sell	-3,048	Closed	-$1.65M	–	10606
2020 Q2	$1.65M	Buy	+3,048	New	+$1.71M	﹤0.01%	4907

Other funds holding PYPD

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

SPM

Symmetry Peak Management Radnor, Pennsylvania $369M AUM 148.4% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.87B AUM 46.92% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Citadel Advisors's PYPD Position: Q2 2026 in Review

Citadel Advisors reduced its PolyPid (PYPD) stake by 27% in Q2 2026, selling an estimated $71.4K and leaving 42,282 shares worth $215K. The position accounts for ﹤0.01% of the portfolio, ranked #11906.

Citadel Advisors first reported a position in PYPD in Q2 2020 and has held it in 12 quarters since. The position peaked at $1.65M in Q2 2020. 33 funds tracked by Wall St. Rank hold PYPD as of Q2 2026.

Citadel Advisors held 42,282 shares of PolyPid worth $215K as of Q2 2026.
Citadel Advisors sold 15,487 PolyPid shares in Q2 2026, an estimated $71.4K.
PolyPid made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #11906 holding.
Citadel Advisors first reported a position in PolyPid in Q2 2020 and has held it in 12 quarters since.
Citadel Advisors's PolyPid position peaked at $1.65M in Q2 2020.
33 funds tracked by Wall St. Rank held PolyPid as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.